Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Veronica Rendo, Ph.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Khadka P, Reitman ZJ, Lu S, Buchan G, Gionet G, Dubois F, Carvalho DM, Shih J, Zhang S, Greenwald NF, Zack T, Shapira O, Pelton K, Hartley R, Bear H, Georgis Y, Jarmale S, Melanson R, Bonanno K, Schoolcraft K, Miller PG, Condurat AL, Gonzalez EM, Qian K, Morin E, Langhnoja J, Lupien LE, Rendo V, Digiacomo J, Wang D, Zhou K, Kumbhani R, Guerra Garcia ME, Sinai CE, Becker S, Schneider R, Vogelzang J, Krug K, Goodale A, Abid T, Kalani Z, Piccioni F, Beroukhim R, Persky NS, Root DE, Carcaboso AM, Ebert BL, Fuller C, Babur O, Kieran MW, Jones C, Keshishian H, Ligon KL, Carr SA, Phoenix TN, Bandopadhayay P. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation. Nat Commun. 2022 02 01; 13(1):604. PMID: 35105861.
    Citations:    Fields:    Translation:HumansAnimalsCells
  2. Kundu S, Ali MA, Handin N, Conway LP, Rendo V, Artursson P, He L, Globisch D, Sjöblom T. Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis. J Exp Clin Cancer Res. 2021 Jul 07; 40(1):225. PMID: 34233735.
    Citations: 1     Fields:    Translation:Humans
  3. Parnandi N, Rendo V, Cui G, Botuyan MV, Remisova M, Nguyen H, Drané P, Beroukhim R, Altmeyer M, Mer G, Chowdhury D. TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs. Mol Cell. 2021 06 17; 81(12):2583-2595.e6. PMID: 33961797.
    Citations: 2     Fields:    Translation:HumansCells
  4. Joyce J, Wakelee H, Davis MB, Teo SH, Bell S, Rendo V. Women in cancer research and oncology. Cancer Cell. 2021 03 08; 39(3):285-287. PMID: 33689700.
    Citations:    Fields:    Translation:Humans
  5. Rendo V, Kundu S, Rameika N, Ljungström V, Svensson R, Palin K, Aaltonen L, Stoimenov I, Sjöblom T. Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer. Sci Rep. 2020 12 31; 10(1):22436. PMID: 33384440.
    Citations: 2     Fields:    Translation:HumansCells
  6. Rendo V, Enache OM, Ben-David U. Adding to the CASeload: unwarranted p53 signaling induced by Cas9. Mol Cell Oncol. 2020; 7(5):1789419. PMID: 32944644.
    Citations:    
  7. Conway LP, Rendo V, Correia MSP, Bergdahl IA, Sjöblom T, Globisch D. Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N-Acetyltransferase NAT2. Angew Chem Int Ed Engl. 2020 08 17; 59(34):14342-14346. PMID: 32497306.
    Citations: 5     Fields:    Translation:HumansCells
  8. Enache OM, Rendo V, Abdusamad M, Lam D, Davison D, Pal S, Currimjee N, Hess J, Pantel S, Nag A, Thorner AR, Doench JG, Vazquez F, Beroukhim R, Golub TR, Ben-David U. Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nat Genet. 2020 Jul; 52(7):748-749. PMID: 32587373.
    Citations: 6     Fields:    
  9. Enache OM, Rendo V, Abdusamad M, Lam D, Davison D, Pal S, Currimjee N, Hess J, Pantel S, Nag A, Thorner AR, Doench JG, Vazquez F, Beroukhim R, Golub TR, Ben-David U. Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nat Genet. 2020 07; 52(7):662-668. PMID: 32424350.
    Citations: 43     Fields:    Translation:HumansCells
  10. Rendo V, Stoimenov I, Sjöblom T. Targeting tumor vulnerabilities associated with loss of heterozygosity. Mol Cell Oncol. 2020; 7(4):1759390. PMID: 32944621.
    Citations:    
  11. Rendo V, Stoimenov I, Mateus A, Sjöberg E, Svensson R, Gustavsson AL, Johansson L, Ng A, O'Brien C, Giannakis M, Artursson P, Nygren P, Cheong I, Sjöblom T. Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy. Nat Commun. 2020 03 11; 11(1):1308. PMID: 32161261.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  12. Pandzic T, Rendo V, Lim J, Larsson C, Larsson J, Stoimenov I, Kundu S, Ali MA, Hellström M, He L, Lindroth AM, Sjöblom T. Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth. Oncotarget. 2017 Nov 17; 8(58):98646-98659. PMID: 29228717.
    Citations: 6     Fields:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Rendo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.